Zhengye Biotechnology Holding ZYBT
NASDAQ ZYBT
$1.24 -0.02 (-1.59%)
At close: Oct 2, 2026 · 4:00 PM EDT

Zhengye Biotechnology Holding (ZYBT) Other Accumulated Expenses (2023 - 2025)

Updated

Zhengye Biotechnology Holding (ZYBT) posted Other Accumulated Expenses of $20,585 for the quarter ended Dec 31, 2025, up 1.3% from $20,325 a year earlier.

Analysis

Zhengye Biotechnology Holding (ZYBT) Other Accumulated Expenses (2023 - 2025) Analysis & Trends

As of Dec 31, 2025, Zhengye Biotechnology Holding's Other Accumulated Expenses came in at -$146,000.

  • In prior years, Zhengye Biotechnology Holding's Other Accumulated Expenses was $20,000 in the year ended Dec 31, 2024, -$5.77 million in the year ended Dec 31, 2023 and -$5.15 million in the year ended Dec 31, 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Zhengye Biotechnology Holding 58.77 Mn 46.15 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 20,584.92
Jun 30, 2025 -3.25 Mn
Dec 31, 2024 20,325.50
Dec 31, 2023 -5.66 Mn
API Access

Zhengye Biotechnology Holding Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ZYBT&period=max&api_key=YOUR_API_KEY